Showing results (1-10 of 535) with videos related to
Sort By:
Pageof 54
International Journal of Clinical & Laboratory Research|January 1, 1992
Interleukin-3 in the treatment of myelodysplastic syndromesA Ganser, O G Ottmann, D HoelzerOnkologie|February 1, 1989
Recombinant human granulocyte-macrophage colony-stimulating factor and low-dose cytosine arabinoside in patients with myelodysplastic syndrome. A pilot studyA Ganser, O G Ottmann, G Schulz, et al.Leukemia|May 1, 1992
Acute lymphoblastic leukemia with the (4;11) translocation: combined cytogenetic, immunological and molecular genetic analysesC Schardt, O G Ottmann, D Hoelzer, et al.Annals of Internal Medicine|December 1, 1989
The effect of recombinant human granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity in chronic severe neutropeniaA Ganser, O G Ottmann, H Erdmann, et al.Annals of Hematology|April 1, 1994
Induction of soluble IL-2 receptor in patients with myelodysplastic syndromes undergoing high-dose interleukin-3 treatmentG Seipelt, A Ganser, H Duranceyk, et al.British Journal of Haematology|August 1, 1993
Induction of TNF-alpha in patients with myelodysplastic syndromes undergoing treatment with interleukin-3G Seipelt, A Ganser, H Duranceyk, et al.Blood|October 15, 1990
Effects of recombinant human interleukin-3 on human hematopoietic progenitor and precursor cells in vivoO G Ottmann, A Ganser, G Seipelt, et al.Leukemia Research|January 28, 1999
Growth factors in the treatment of acute lymphoblastic leukemiaO G Ottmann, D HoelzerAnnals of Hematology|May 1, 1991
Effect of recombinant human transforming growth factor beta and tumor necrosis factor alpha on bone marrow progenitor cells of HIV-infected personsR G Geissler, O G Ottmann, M Eder, et al.Praxis|October 23, 1998
[Growth factors in oncology: effectiveness and prospects]O G Ottmann, D HoelzerPageof 54